LATISSE .3 mg/mL

LATISSE .3 mg/mL is an ophthalmic solution containing bimatoprost, designed to promote eyelash growth. This FDA-approved treatment is applied nightly to the base of the upper eyelashes.

LATISSE .3 mg/mL is primarily used to treat hypotrichosis, a condition characterized by inadequate or not enough lashes. This solution helps to enhance the length, thickness, and darkness of eyelashes. Users often seek LATISSE for eyelash growth, aiming to achieve fuller and more noticeable lashes. The active ingredient, bimatoprost, works by prolonging the anagen phase of the eyelash hair cycle, leading to improved lash appearance over time.

Common effects of using LATISSE .3 mg/mL include gradual improvement in eyelash length, thickness, and darkness. Users may notice visible changes within a few weeks of consistent use. Some individuals might experience temporary eye redness, itching, or darkening of the eyelid skin. These effects are generally mild and temporary, but persistent issues should be discussed with a healthcare provider.

LATISSE .3 mg/mL should be used as directed and only applied to the skin of the upper eyelid margin at the base of the upper eyelashes. Avoid contact with the eyes, as it may cause irritation. Keep the bottle tightly closed when not in use to prevent contamination. Store at room temperature away from direct sunlight and out of reach of children. Always follow the instructions provided with the product.

LATISSE .3 mg/mL may interact with other ophthalmic medications. It is advisable to consult a healthcare provider before using this solution if you are currently using other eye treatments. Additionally, avoid using LATISSE in conjunction with contact lenses. Remove contact lenses before application and wait at least 15 minutes before reinserting them. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.